查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827369

血庫市場按產品類型、應用、最終用戶、測試類型、採集方法和捐贈者類型分類－2025-2032 年全球預測

Blood Banking Market by Product Type, Application, End User, Testing Type, Collection Method, Donor Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，血庫市場將成長 463.1 億美元，複合年成長率為 13.43%。

主要市場統計數據
基準年2024年 168.9億美元
預計2025年 191.5億美元
預測年份：2032年 463.1億美元
複合年成長率（%） 13.43%

探索現代血庫格局，其中臨床需求、捐贈者多樣性、檢測進步和運作彈性融合，重新定義病患照護服務

血庫產業正處於臨床需求、技術加速發展和供應鏈現狀變化的關鍵交匯點。捐贈者篩檢、自動化採血和分子檢測的進步正在改變血液成分的採購、處理和與接受者配對的方式，而人口和流行病學壓力正在重塑需求模式。臨床相關人員和實踐領導者越來越關注整個採血網路的彈性、檢測的可靠性，以及在不中斷臨床服務的情況下整合新的安全模式的能力。

從門診手術中心到大型醫院系統，在臨床環境中，越來越需要在保持充足庫存的同時最大限度地降低輸血風險。這項驅動力正在刺激病原體去活化技術、自動化單採系統和增強型傳染病檢查平台的投資。同時，捐贈者群體也呈現多樣化，家庭替代捐獻者、有償捐獻者和自願捐獻者在招募、留存和合規性方面各自體現著不同的運作考量。捐贈者類型和採集方法（全血採集 vs. 單採）之間的相互作用決定了處理工作流程和下游檢測的優先順序。

在未來幾年，那些將臨床實踐與強大的捐贈者參與、可靠的檢測通訊協定和靈活的供應策略相結合的組織將最有能力提供安全的輸血服務。本引言透過將臨床優先事項與營運槓桿聯繫起來，為後續分析奠定了基礎，為深入探討隨之而來的技術、監管和地緣政治變化奠定了基礎。

技術進步、臨床實踐變化、監管加強以及供應鏈彈性如何重塑整個血庫系統的營運重點

在技​​術創新、臨床實踐發展以及供應鏈韌性需求的推動下，血庫格局正在經歷轉型變革。新型病原體去活化系統和先進的核酸檢測技術正在提升安全基準，使血液服務更有效地降低輸血傳播感染的風險。同時，血液分離和全血處理的自動化正在簡化流程，減少人工操作的差異，並支持更高品質的成分製備。伴隨這項技術變革的是，越來越多的數位互動平台被用於招募和留住自願捐血者，從而改善捐血體驗，同時最佳化採血計畫和庫存預測。

臨床變化同樣重要。患者血液管理計劃和精準輸血策略最大限度地減少不必要的輸血，並優先匹配特定成分類型，例如血小板、紅血球、血漿和冷沉澱，以滿足個別患者的需求。因此，診斷檢測和快速血型分析以支持個人化輸血決策正變得越來越重要。與這些臨床趨勢同步，法律規範也不斷發展，強調加強感染疾病監測和更嚴格的檢測方法驗證。這些監管變化推動了對經過驗證的檢測技術和品管系統的投資。

在營運方面，該產業正在汲取過去供應中斷的教訓，透過多元化供應商關係、投資低溫運輸物流以及探索本地生產和加工方案。在對能夠提供高吞吐量、安全性和可追溯性的整合解決方案的需求推動下，血庫、醫院/診所和診斷設備製造商之間的跨部門合作正變得越來越普遍。總而言之，這些轉變正在重新調整血液服務機構在資本配置、員工發展和策略性夥伴關係關係方面的優先順序，以滿足臨床醫生和患者日益成長的期望。

評估關稅波動和貿易政策動態如何增加採購複雜性並推動血庫營運的策略供應鏈調整

關稅調整和貿易政策格局對血庫設備、耗材和診斷劑的採購模式產生了重大影響。關鍵製造投入和成品醫療設備的進口關稅上調，可能會增加用於檢測、加工和收集的設備和耗材的到岸成本。這些發展趨勢促使採購團隊重新評估其供應商組合，盡可能優先考慮本地或區域生產，並尋求合約保護以吸收短期成本波動。對於臨床項目而言，實際結果是，成本可預測性是選擇檢測平台或擴大血液分離能力的關鍵考慮因素。

除了直接影響價格外，關稅相關的不確定性還會延長前置作業時間，並使庫存規劃更加複雜。製造商和經銷商可能會調整其分銷策略以對沖關稅波動，迫使血庫和醫院建立更強大的庫存緩衝，或尋找可行的替代設備和試劑供應商。因此，採購和臨床工程部門必須更緊密地合作，評估供應商之間的等效性，並在不影響臨床性能或法規合規性的前提檢驗替代產品。

此外，關稅可能成為近岸外包和區域供應鏈發展的催化劑，促使供應商在更靠近終端市場的地方建立製造和組裝業務。雖然此類轉變可以增強長期韌性，但需要資本投入和時間，因此企業應優先進行情境規劃，與供應商進行主動談判，並將總擁有成本分析納入採購決策。最終，關稅變動的累積影響凸顯了策略採購管治、跨職能應變計畫和敏捷營運對於維持安全輸血服務連續性的重要性。

詳細的細分分析揭示了產品類型、測試方法、收集方法、捐贈者類別、應用程式和最終用戶設定如何需要差異化的營運和臨床策略

對細分市場的細緻理解對於協調臨床路徑、採購選擇和營運模式至關重要。依產品類型進行分析可以揭示冷沉澱、血漿、血小板、紅血球和全血等成分在物流和臨床需求方面的差異，每種成分都需要特定的採集、儲存和檢測工作流程，從而影響保存期限和配送策略。診斷、研究和輸血用例中應用主導的差異決定了所需檢測的深度，並影響了可追溯性和文件記錄方面的優先級，尤其是在研究應用可能需要額外樣本和資料處理的情況下。

門診手術中心、血庫、醫院和診所各自在容量、人員配備和設施限制方面都存在差異。區分檢測類型（血型檢測和傳染病檢查）有助於明確技術選擇和品管方法。考慮採集方法（單採血與全血採集）有助於明確在捐贈者時間負擔、成分產量和下游處理複雜性方面的權衡，從而影響捐贈者參與策略和容量規劃。

按捐贈者類型細分進一步增加了實踐設計的複雜性。家庭替代捐贈者、付費捐贈者和自願捐贈者各自體現出獨特的倫理、監管和物流方面的問題，這些方面會影響招募工作和社區推廣。綜合考慮這些細分因素，服務提供者和供應商能夠根據不同客戶和患者群體的特定臨床和營運需求，調整其產品系列、檢測演算法和服務交付模式。

美洲、歐洲、中東和非洲以及亞太地區的差異如何影響營運重點、監管回應和供應恢復策略

區域動態在塑造血庫工作的重點和能力方面發揮關鍵作用。在美洲，成熟的血庫網路和一體化的醫院系統創造了整合、採用先進檢測手段和集中庫存管理的良好環境。該地區高度重視臨床標準化和捐贈者招募宣傳活動，支持持續改善血庫成分的使用實踐和品質系統。

在歐洲、中東和非洲，衛生系統的成熟度各不相同，因此營運模式也各有不同。該地區的高所得市場強調嚴格的監管合規、分子檢測的採用以及對病原體去活化方法的投資，而資源匱乏的地區則優先考慮可擴展的採集策略、低溫運輸物流和能力建設。官民合作關係和區域計劃通常可作為傳播最佳實踐和標準化培訓的機制，從而加強緊急應變和稀缺捐助者管理的跨國合作。

亞太地區的人口結構變化和快速的醫療保健現代化進程加速了對強大的採集和檢測基礎設施的需求。該地區對自動化血液分離系統和照護現場血型檢測技術的投資正在增加，同時也引入了集中式和分散式採集模式。該地區的政策制定者和醫療保健提供者也在探索本地製造機會，以減少對國際供應鏈的依賴，增強對貿易相關中斷的抵禦能力，並改善關鍵耗材的取得。

檢驗製造商、診斷公司和服務供應商如何投資自動化、夥伴關係和安全創新，以重新調整其競爭定位和臨床價值

關鍵產業參與者，包括設備供應商、診斷製造商、檢測實驗室和血漿分餾，是創新、策略夥伴關係和產能擴張的核心。領先的製造商持續投資於自動化和儀器互通性，以減少手動任務並提高可追溯性，而診斷公司則正在加速開發多重檢測和快速血型分型解決方案，以加快臨床決策速度。設備製造商和實驗室之間的合作也在不斷擴大，這有助於提供包含硬體、試劑和驗證支援的一體化服務。

隨著企業尋求擴大臨床產品組合併確保下游銷售管道，策略夥伴關係和定向收購正在塑造競爭格​​局。為了滿足日益成長的安全預期，一些公司優先投資病原體減少技術並擴展試劑庫。同時，專注於血液採集技術的供應商正在改進血液分離系統的人體工學和吞吐量，以改善捐血者的體驗並提高每次採血的產量，使醫院和血庫等最終用戶能夠更輕鬆地採用新方法，同時保持符合監管標準。

為臨床領導、採購團隊和技術合作夥伴提供切實可行的建議，以提高血庫系統的安全性、供應彈性和營運效率

臨床服務、採購和製造領導者應優先考慮一系列協作行動，將新洞察轉化為營運韌性和臨床品質。首先，建立多元化的供應商關係，並為關鍵耗材和設備尋找合格的替代供應商，以降低單一供應商風險並緩解關稅帶來的成本波動。此外，應結合包含價格調整條款和庫存寄售模式的合約策略，以平衡成本控制和可用性。

投資診斷和處理技術，以提高安全性和通量。採用先進的傳染病檢查平台和病原體去活化系統可以降低臨床風險並簡化法規遵從性，而採集和成分處理的自動化可以減少差異性和勞動強度。在進行技術投資的同時，透過數位平台來簡化自願捐贈者的預約和保留流程，從而增強捐贈者的參與度，並在適用的情況下，根據家庭替代和付費捐贈者群體的特點，實施推廣客製化的推廣計劃。

在營運方面，我們將制定一套跨職能的緊急時應對計畫，整合臨床工程、供應鏈和物流領導團隊，確保在發生中斷時快速檢驗替代產品並實現無縫銜接。我們將透過數據驅動的補貨觸發機制和基於場景的庫存策略，加強低溫運輸物流和庫存管治。最後，我們將投資於員工發展和能力建設項目，以確保臨床和實驗室負責人能夠有效操作新平台並維護高品質的文檔，以滿足不斷變化的監管要求。

結合相關人員訪談、技術檢驗和與二手資訊最後覆核的多方法研究方法將產生可靠且可操作的發現。

本分析基於結構化研究方法，將與該領域相關人員的初步定性接觸與嚴格的次要證據基準相結合。初步研究包括對血庫營運負責人、臨床實驗室主任、採購主管和醫療技術供應商進行半結構化訪談，以了解他們對技術採用、捐贈策略和供應鏈限制的第一手觀點。這些見解與第二手資料（包括監管指南、血液採集和檢測平台的技術規範、同行評審的輸血安全臨床文獻以及公開的公司資訊披露）進行了整合，以檢驗趨勢並協調不同的敘述。

數據整合優先考慮臨床、營運和供應鏈領域主題的融合。在可能的情況下，技術規格和監管要求與製造商文件和已發布的標準進行交叉引用，以確保準確性。在整個研究過程中，我們關注最終使用者和區域差異，並認知到異質醫療環境的固有限制。研究結果由具有臨床實驗室和輸血醫學經驗的專家進行審查，以檢驗其實際適用性，並揭示其在實際實踐中實施的細微影響。

總結相關性、技術採用和跨職能協作是維持臨床安全和營運連續性的支柱

現代血庫環境既帶來挑戰，也帶來機遇，需要採取協調一致的策略應對措施。檢測和處理技術的進步擴展了臨床醫生和操作人員可用的套件，而捐贈者的多樣性和區域差異性則要求採取靈活、因地制宜的方法。貿易政策變化和供應鏈中斷進一步加劇了營運的複雜性，必須透過多元化採購和主動的緊急時應對計畫來積極應對。

將臨床品質要求與嚴格的採購管治相結合，投資於可提高安全性和吞吐量的技術，並在整個供應鏈中建立牢固夥伴關係關係的組織，將能夠更好地維持醫療服務的連續性。未來的道路強調韌性、數據主導的決策以及將臨床目標與實際採購和營運能力相結合的適應性策略。透過專注於這些優先事項，相關人員可以維護安全的輸血服務，並更有效地應對新出現的風險和機會。

目錄

第1章：前言

第2章 研究方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 擴大病原體減少技術以提高血液安全性和保存期限
  • 實施區塊鏈解決方案，確保血液供應鏈的安全可追溯性和法規遵循
  • 建立分散式微型血液中心，改善農村社區的血液獲取服務
  • 用於快速血型鑑定和感染篩檢的可攜式和就地檢驗設備的進展
  • 細胞療法投資的增加推動了對專用血液成分處理設備的需求
  • 血庫和遠端醫療平台之間的合作正在不斷加強，以招募和留住虛擬捐贈者。
  • 機器學習模型的出現可以預測捐贈者延期風險並最佳化招募策略
  • 整合3D生物列印技術，實現人工血液和血漿替代品的大規模生產

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第 8 章：血庫市場（依產品類型）

  • 冷沉澱
  • 電漿
  • 血小板
  • 紅血球
  • 全血

第9章血庫市場的應用

  • 診斷
  • 研究
  • 輸血

第 10 章。血庫市場（依最終用戶分類）

  • 門診手術中心
  • 血庫
  • 醫院和診所

第 11 章 血庫市場（依測試類型）

  • 血型檢測
  • 傳染病檢查

第 12 章：以採集方式分類的血庫市場

  • 血液成分採集
  • 全血採集

第13章血庫市場（依捐贈者類型）

  • 家庭替代捐贈者
  • 付費捐贈者
  • 自願捐獻者

第14章血庫市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章血庫市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 16 章：各國血庫市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Haemonetics Corporation
    • Grifols, SA
    • Terumo Corporation
    • Fresenius Kabi AG
    • Macopharma SA
    • Bio-Rad Laboratories, Inc.
    • QuidelOrtho Corporation
    • Immucor, Inc.
    • Cerus Corporation
    • Hologic, Inc.
Product Code: MRR-434CCDA04D00

The Blood Banking Market is projected to grow by USD 46.31 billion at a CAGR of 13.43% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.89 billion
Estimated Year [2025] USD 19.15 billion
Forecast Year [2032] USD 46.31 billion
CAGR (%) 13.43%

Introducing the contemporary blood banking landscape where clinical demands, donor diversity, testing advances, and operational resilience converge to redefine patient care delivery

The blood banking field stands at a pivotal confluence of clinical necessity, technological acceleration, and shifting supply chain realities. Advances in donor screening, automated collection, and molecular testing have altered how blood components are sourced, processed, and matched to recipients, while demographic and epidemiological pressures are reshaping demand patterns. Clinical stakeholders and operations leaders are increasingly focused on resilience across collection networks, testing reliability, and the ability to integrate new safety modalities without disrupting clinical delivery.

Across clinical settings, from ambulatory surgical centers to large hospital systems, the imperative to minimize transfusion risks while maintaining adequate inventories has intensified. This dynamic has stimulated investment in pathogen reduction technologies, automated apheresis systems, and enhanced infectious disease testing platforms. At the same time, the donor landscape is diversifying: family replacement donors, paid donors, and voluntary donors present different operational considerations for recruitment, retention, and regulatory compliance. The interplay between donor type and collection method-whether whole blood collection or apheresis collection-shapes processing workflows and downstream testing priorities.

In the coming years, organizations that align clinical practice with robust donor engagement, reliable testing protocols, and adaptive supply strategies will be best positioned to deliver safe transfusion services. This introduction frames the ensuing analysis by connecting clinical priorities with operational levers, setting the context for deeper consideration of technological, regulatory, and geopolitical shifts that follow.

How technological advancement, clinical practice changes, regulatory tightening, and supply chain resilience are collectively reshaping operational priorities across blood banking systems

The blood banking landscape is undergoing transformative shifts driven by technological innovation, clinical practice evolution, and the imperative of supply chain resilience. Novel pathogen reduction systems and advanced nucleic acid testing have raised the safety baseline, enabling blood services to mitigate transfusion-transmitted risks more effectively. Simultaneously, automation in apheresis and whole blood processing streamlines throughput, reduces manual variability, and supports higher-quality component preparation. These technological shifts are complemented by the increasing adoption of digital engagement platforms to recruit and retain voluntary donors, improving donor experience while optimizing collection scheduling and inventory forecasting.

Clinical change is equally significant. Patient blood management programs and precision transfusion strategies prioritize minimizing unnecessary transfusions and matching specific component types-such as platelets, red blood cells, plasma, and cryoprecipitate-to individual patient needs. As a result, diagnostic testing and rapid blood grouping are taking on heightened importance to support tailored transfusion decisions. Alongside these clinical trends, regulatory frameworks continue to evolve, emphasizing enhanced surveillance for infectious agents and stricter validation of testing methodologies. This regulatory tightening incentivizes investments in validated testing technologies and quality management systems.

Operationally, the sector is responding to the lessons of prior supply disruptions by diversifying supplier relationships, investing in cold-chain logistics, and exploring local manufacturing and processing options. Cross-sector collaborations between blood banks, hospitals and clinics, and diagnostic manufacturers are becoming more common, driven by the need for integrated solutions that deliver on throughput, safety, and traceability. Taken together, these shifts are recalibrating how blood services prioritize capital allocation, workforce development, and strategic partnerships to meet rising expectations from clinicians and patients alike.

Evaluating how tariff shifts and trade policy dynamics are intensifying procurement complexity and prompting strategic supply chain adaptation across blood banking operations

Tariff adjustments and trade policy developments have a material influence on the procurement landscape for blood banking equipment, consumables, and diagnostic reagents. Increases in import duties on key manufacturing inputs and finished medical devices can raise landed costs for instrumentation and disposables used in testing, processing, and collection. This dynamic prompts procurement teams to reassess supplier portfolios, prioritize local or regional manufacturing where feasible, and seek contractual protections that absorb short-term cost fluctuations. For clinical programs, the practical consequence is a heightened focus on cost predictability when selecting testing platforms or scaling up apheresis capabilities.

Beyond direct price effects, tariff-related uncertainty can elongate lead times and complicate inventory planning. Manufacturers and distributors may adjust distribution strategies to hedge against tariff volatility, which in turn requires blood banks and hospitals to build more robust inventory buffers or to qualify alternate validated devices and reagent sources. Procurement and clinical engineering functions therefore must collaborate more closely to evaluate equivalency across suppliers and to validate alternate products without compromising clinical performance or regulatory compliance.

Furthermore, tariffs can act as a catalyst for nearshoring and regional supply chain development, incentivizing suppliers to establish manufacturing or assembly operations closer to end markets. While such shifts can enhance long-term resilience, they also require capital investment and time, so organizations should prioritize scenario planning, engage in proactive supplier negotiations, and incorporate total-cost-of-ownership analyses into purchasing decisions. Ultimately, the cumulative effects of tariff dynamics underscore the importance of strategic procurement governance, cross-functional contingency planning, and agile operations to maintain continuity of safe transfusion services.

Deep segmentation analysis reveals how product types, testing modalities, collection methods, donor categories, applications, and end-user settings demand differentiated operational and clinical strategies

A nuanced understanding of segmentation is essential for tailoring clinical pathways, procurement choices, and operational models. When analyzed by product type, differences emerge between the logistical and clinical requirements for components such as cryoprecipitate, plasma, platelets, red blood cells, and whole blood, each demanding specific collection, storage, and testing workflows that affect shelf life and distribution strategies. Application-driven differentiation-spanning diagnostics, research, and transfusion use cases-shapes the depth of testing required and influences priorities around traceability and documentation, especially where research applications may require additional sample processing and data handling.

End-user contexts also prescribe operational distinctions: ambulatory surgical centers, blood banks, and hospitals and clinics each operate under different throughput, staffing, and facility constraints, meaning that solutions must be calibrated to fit institutional scale and clinical intensity. Testing type segmentation, separating blood grouping testing from infectious disease testing, clarifies technology selection and quality control approaches because these testing categories carry distinct regulatory pathways and validation requirements. Collection method considerations-comparing apheresis collection with whole blood collection-highlight trade-offs in donor time commitment, component yield, and downstream processing complexity, which have implications for donor engagement strategies and capacity planning.

Donor type segmentation further complicates operational design. Family replacement donors, paid donors, and voluntary donors each present unique ethical, regulatory, and logistical dimensions that impact recruitment practices and community outreach. Taken together, these segmentation lenses enable providers and suppliers to align product portfolios, testing algorithms, and service delivery models with the specific clinical and operational needs of diverse customers and patient populations.

How regional variations across the Americas, Europe Middle East & Africa, and Asia-Pacific produce distinct operational priorities, regulatory responses, and supply resilience strategies

Regional dynamics play a pivotal role in shaping blood banking priorities and capabilities. In the Americas, established networks of blood banks and integrated hospital systems create an environment where consolidation, advanced testing adoption, and centralized inventory management are prevalent. This region's focus on clinical standardization and donor recruitment campaigns supports continued refinement of component utilization practices and quality systems.

Across Europe, Middle East & Africa, heterogeneity in health system maturity drives diverse operational models. High-income markets within the region emphasize rigorous regulatory compliance, molecular testing adoption, and investment in pathogen reduction methodologies, while lower-resource settings prioritize scalable collection strategies, cold-chain logistics, and capacity building. Public-private partnerships and regional initiatives often serve as mechanisms to spread best practices and standardize training, enhancing cross-border collaboration in emergency responses and rare-donor management.

In Asia-Pacific, population dynamics and rapid healthcare modernization are accelerating demand for robust collection and testing infrastructure. The region exhibits a mix of centralized and distributed collection models, with increasing investment in automated apheresis systems and point-of-care blood grouping technologies. Policymakers and providers in this region are also exploring regional manufacturing opportunities to reduce dependence on long international supply lines, thereby strengthening resilience against trade-related disruptions and improving access to critical consumables.

Examining how manufacturers, diagnostics firms, and service providers are investing in automation, partnerships, and safety innovations to realign competitive positioning and clinical value

Key industry participants have become focal points for innovation, strategic partnerships, and capacity expansion, with activity spanning equipment suppliers, diagnostic manufacturers, testing laboratories, and plasma fractionators. Leading manufacturers continue to invest in automation and device interoperability to reduce manual touches and improve traceability, while diagnostic firms are accelerating development of multiplexed assays and rapid blood grouping solutions that enable faster clinical decision making. Collaborative arrangements between equipment makers and testing laboratories are also growing, facilitating integrated service offerings that bundle hardware, reagents, and validation support.

Strategic partnerships and targeted acquisitions are shaping the competitive landscape as companies seek to broaden their clinical portfolios or secure downstream distribution channels. Some organizations are prioritizing investments in pathogen reduction technologies and expanded reagent libraries to meet heightened safety expectations. Meanwhile, suppliers focused on collection technologies are advancing apheresis system ergonomics and throughput, improving donor experience and supporting higher yield per collection event. Across the sector, there is a clear emphasis on building solutions that address both clinical efficacy and operational efficiency, enabling end users such as hospitals and blood banks to more readily adopt new modalities while maintaining compliance with regulatory standards.

Actionable recommendations for clinical leaders, procurement teams, and technology partners to fortify safety, supply resilience, and operational efficiency within blood banking systems

Leaders in clinical services, procurement, and manufacturing should prioritize a set of coordinated actions that translate emerging insights into operational resilience and clinical quality. First, diversify supplier relationships and qualify alternate validated vendors for critical consumables and instruments to reduce single-source exposure and mitigate tariff-driven cost volatility. Complement this with contractual strategies that include price adjustment clauses and inventory consignment models to balance cost management with availability.

Invest in diagnostic and processing technologies that strengthen the safety envelope while improving throughput. Adoption of advanced infectious disease testing platforms and pathogen reduction systems can reduce clinical risk and streamline regulatory compliance, while automation in collection and component processing can cut variability and labor intensity. Parallel to technology investments, enhance donor engagement through digital platforms that simplify scheduling and retention for voluntary donors, and tailor outreach programs to the characteristics of family replacement and paid donor pools when applicable.

Operationally, develop cross-functional contingency plans that integrate clinical engineering, supply chain, and clinical leadership to ensure rapid validation of alternate products and seamless substitution during disruptions. Strengthen cold-chain logistics and inventory governance using data-driven replenishment triggers and scenario-based stock policies. Finally, invest in workforce training and competency programs to ensure clinical staff and laboratory personnel can operate new platforms effectively and maintain quality documentation to meet evolving regulatory expectations.

Description of the multi-method research approach combining stakeholder interviews, technical validation, and cross-checked secondary sources to ensure robust and actionable findings

This analysis is grounded in a structured research approach combining primary qualitative engagement with sector stakeholders and a rigorous secondary evidence baseline. Primary research involved semi-structured interviews with operational leaders in blood banks, clinical laboratory directors, procurement executives, and medical technology suppliers to capture firsthand perspectives on technology adoption, donor strategies, and supply chain constraints. These insights were triangulated with secondary materials, including regulatory guidance, technical specifications for collection and testing platforms, peer-reviewed clinical literature on transfusion safety, and publicly available company disclosures to validate trends and reconcile differing narratives.

Data synthesis prioritized thematic convergence across clinical, operational, and supply chain domains. Where possible, technical specifications and regulatory requirements were cross-checked against manufacturer documentation and published standards to ensure accuracy. Throughout the research process, attention was given to contextual differences across end users and regions, acknowledging the limitations inherent to heterogeneous healthcare settings. Findings were reviewed by subject-matter experts with clinical laboratory and transfusion medicine experience to validate practical applicability and to surface nuanced implications for implementation in real-world operations.

Concluding synthesis that emphasizes resilience, technological adoption, and cross-functional coordination as the pillars for sustained clinical safety and operational continuity

The contemporary blood banking environment presents both challenges and opportunities that require calibrated, strategic responses. Technological advancements in testing and processing are expanding the toolkit available to clinicians and operators, while donor diversity and regional variability demand flexible and context-sensitive approaches. Trade policy changes and supply chain disruptions add a layer of operational complexity that must be actively managed through diversified sourcing and proactive contingency planning.

Organizations that integrate clinical quality imperatives with disciplined procurement governance, invest in technologies that enhance safety and throughput, and cultivate strong partnerships across the supply chain will be better positioned to maintain continuity of care. The path forward emphasizes resilience, data-driven decision making, and adaptive strategies that align clinical objectives with the realities of sourcing and operational capacity. By focusing on these priorities, stakeholders can sustain safe transfusion services and respond more effectively to emergent risks and opportunities.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Expansion of pathogen reduction technologies to enhance blood safety and shelf life
  • 5.2. Adoption of blockchain solutions for secure traceability and regulatory compliance in blood supply chains
  • 5.3. Implementation of decentralized micro blood centers to increase accessibility in rural communities
  • 5.4. Advances in portable and point-of-care testing devices for rapid blood group and infectious screening
  • 5.5. Rising investment in cellular therapies driving demand for specialized blood component processing equipment
  • 5.6. Growing collaboration between blood banks and telehealth platforms for virtual donor recruitment and retention
  • 5.7. Emergence of machine learning models to predict donor deferral risk and optimize recruitment strategies
  • 5.8. Integration of 3D bioprinting techniques for scalable production of artificial blood and plasma substitutes

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Banking Market, by Product Type

  • 8.1. Cryoprecipitate
  • 8.2. Plasma
  • 8.3. Platelets
  • 8.4. Red Blood Cells
  • 8.5. Whole Blood

9. Blood Banking Market, by Application

  • 9.1. Diagnostics
  • 9.2. Research
  • 9.3. Transfusion

10. Blood Banking Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Blood Banks
  • 10.3. Hospitals And Clinics

11. Blood Banking Market, by Testing Type

  • 11.1. Blood Grouping Testing
  • 11.2. Infectious Disease Testing

12. Blood Banking Market, by Collection Method

  • 12.1. Apheresis Collection
  • 12.2. Whole Blood Collection

13. Blood Banking Market, by Donor Type

  • 13.1. Family Replacement Donor
  • 13.2. Paid Donor
  • 13.3. Voluntary Donor

14. Blood Banking Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Banking Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Banking Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Haemonetics Corporation
    • 17.3.2. Grifols, S.A.
    • 17.3.3. Terumo Corporation
    • 17.3.4. Fresenius Kabi AG
    • 17.3.5. Macopharma SA
    • 17.3.6. Bio-Rad Laboratories, Inc.
    • 17.3.7. QuidelOrtho Corporation
    • 17.3.8. Immucor, Inc.
    • 17.3.9. Cerus Corporation
    • 17.3.10. Hologic, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. BLOOD BANKING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. BLOOD BANKING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BLOOD BANKING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BLOOD BANKING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD BANKING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD BANKING MARKET SIZE, BY CRYOPRECIPITATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD BANKING MARKET SIZE, BY PLASMA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD BANKING MARKET SIZE, BY PLATELETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD BANKING MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD BANKING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD BANKING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD BANKING MARKET SIZE, BY TRANSFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD BANKING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD BANKING MARKET SIZE, BY HOSPITALS AND CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD BANKING MARKET SIZE, BY BLOOD GROUPING TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD BANKING MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD BANKING MARKET SIZE, BY APHERESIS COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD BANKING MARKET SIZE, BY WHOLE BLOOD COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD BANKING MARKET SIZE, BY FAMILY REPLACEMENT DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD BANKING MARKET SIZE, BY PAID DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD BANKING MARKET SIZE, BY VOLUNTARY DONOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD BANKING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL BLOOD BANKING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 255. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. GCC BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. GCC BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 262. GCC BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 263. GCC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GCC BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. GCC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 266. GCC BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 267. GCC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. GCC BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 284. BRICS BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 285. BRICS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 286. BRICS BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 287. BRICS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. BRICS BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. G7 BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. G7 BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. G7 BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. G7 BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. G7 BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 303. G7 BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. G7 BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 305. G7 BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. G7 BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. G7 BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 308. G7 BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 309. G7 BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. G7 BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. NATO BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. NATO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 314. NATO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 315. NATO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 316. NATO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 317. NATO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 318. NATO BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 319. NATO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. NATO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. NATO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 322. NATO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 323. NATO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. NATO BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 326. GLOBAL BLOOD BANKING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 327. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 328. UNITED STATES BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 329. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 330. UNITED STATES BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 331. UNITED STATES BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 332. UNITED STATES BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 337. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. UNITED STATES BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. CANADA BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. CANADA BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. CANADA BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 344. CANADA BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 345. CANADA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 346. CANADA BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 347. CANADA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)
  • TABLE 348. CANADA BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2025-2032 (USD MILLION)
  • TABLE 349. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2018-2024 (USD MILLION)
  • TABLE 350. CANADA BLOOD BANKING MARKET SIZE, BY DONOR TYPE, 2025-2032 (USD MILLION)
  • TABLE 351. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 352. MEXICO BLOOD BANKING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 353. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 354. MEXICO BLOOD BANKING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 355. MEXICO BLOOD BANKING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 356. MEXICO BLOOD BANKING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 357. MEXICO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
  • TABLE 358. MEXICO BLOOD BANKING MARKET SIZE, BY TESTING TYPE, 2025-2032 (USD MILLION)
  • TABLE 359. MEXICO BLOOD BANKING MARKET SIZE, BY COLLECTION METHOD, 2018-2024 (USD MILLION)

TABLE 360